Literature DB >> 22262225

Candida keratitis: emerging problem in India.

Jayangshu Sengupta1, Archana Khetan, Suman Saha, Debdulal Banerjee, Nibaran Gangopadhyay, Dipanjan Pal.   

Abstract

PURPOSE: To determine the epidemiological characteristics and outcome of Candida keratitis in a Cornea Care Unit of Kolkata-based tertiary eye hospital.
METHODS: A retrospective, noncomparative, observational case series involving patients of culture-proven fungal keratitis from January 2008 to December 2008. A total of 85 cases of culture-proven fungal keratitis were identified. Of these, 16 cases were caused by Candida sp and selected for the study. The records were analyzed for demographics, risk factors, mode of management (medical or surgical), indication of surgical therapy, and the response to treatment with final outcome. Medical therapy consisted of topical amphotericin B with or without intracameral application after obtaining culture reports. Surgical therapy included application of tissue adhesive with bandage contact lens and therapeutic keratoplasty.
RESULTS: All cases of Candida keratitis were caused by Candida albicans accounting for 16 cases [18.81%; 95% confidence interval (CI), 11.8-28.5] of total culture-positive fungal keratitis. We found postsurgical steroid therapy in 8 cases as most important association, followed by diabetes and trauma (4 cases each) as next common comorbidities. All patients required therapeutic keratoplasty. Surgical indications were corneal melt in 10 cases (62.5%; 95% CI, 38.5-81.6), extension up to limbus in 2 cases (12.5%; 95% CI, 12.2-37.2) and nonresponse with worsening in 4 cases (25%; 95% CI, 19.7-49.9). Final outcome consists of phthisis bulbi in 3 cases (18.8%; 95% CI, 5.8-43.8), failed graft in 7 cases (43.7%; 95% CI, 23-66.8), and clear graft in 6 cases (37.5%; 95% CI, 18.4-61.5).
CONCLUSIONS: Candida is a new concern in developing countries like India. We are concerned about the poorer outcome, probably resulting from our unpreparedness and failure of medical therapy leading to more complication and requiring surgical intervention in higher numbers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262225     DOI: 10.1097/ICO.0b013e31823f8a71

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Contact lens-related polymicrobial keratitis: Acanthamoeba spp. genotype T4 and Candida albicans.

Authors:  Maria Luiza Carneiro Buchele; Débora Borgert Wopereis; Fabiana Casara; Jefferson Peres de Macedo; Marilise Brittes Rott; Fabíola Branco Filippin Monteiro; Maria Luiza Bazzo; Fernando Dos Reis Spada; Jairo Ivo Dos Santos; Karin Silva Caumo
Journal:  Parasitol Res       Date:  2018-08-10       Impact factor: 2.289

2.  Intracorneal Amphotericin B Injection in a Case of Indolent Candidal Keratitis.

Authors:  Jyoti Deswal; Sudesh Kumar Arya
Journal:  J Clin Diagn Res       Date:  2017-05-01

3.  Etiological Analysis of Fungal Keratitis and Rapid Identification of Predominant Fungal Pathogens.

Authors:  Dan He; Jilong Hao; Song Gao; Xue Wan; Wanting Wang; Qiushi Shan; Li Wang
Journal:  Mycopathologia       Date:  2015-10-07       Impact factor: 2.574

4.  Endothelial Plaques as Sign of Hyphae Infiltration of Descemet's Membrane in Fungal Keratitis.

Authors:  Xiaolin Qi; Ting Liu; Man Du; Hua Gao
Journal:  J Ophthalmol       Date:  2020-05-26       Impact factor: 1.909

5.  Risk Factors of Microbial Keratitis in Uganda: A Case Control Study.

Authors:  Simon Arunga; Guyguy M Kintoki; Stephen Gichuhi; John Onyango; Bosco Ayebazibwe; Rob Newton; Astrid Leck; David Macleod; Victor H Hu; Matthew J Burton
Journal:  Ophthalmic Epidemiol       Date:  2019-10-22       Impact factor: 1.648

6.  Evaluation of ligand modified poly (N-Isopropyl acrylamide) hydrogel for etiological diagnosis of corneal infection.

Authors:  Nagaveni Shivshetty; Thomas Swift; Abigail Pinnock; David Pownall; Sheila Mac Neil; Ian Douglas; Prashant Garg; Stephen Rimmer
Journal:  Exp Eye Res       Date:  2021-12-03       Impact factor: 3.770

7.  Chlorhexidine gluconate 0.2% as a treatment for recalcitrant fungal keratitis in Uganda: a pilot study.

Authors:  Simon Arunga; Tumu Mbarak; Abel Ebong; James Mwesigye; Dan Kuguminkiriza; Abeer H A Mohamed-Ahmed; Jeremy John Hoffman; Astrid Leck; Victor Hu; Matthew Burton
Journal:  BMJ Open Ophthalmol       Date:  2021-07-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.